Bioceres Crop Solutions Corp.

NASDAQ:BIOX

6.84 (USD) • At close November 13, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q1
Revenue 124.31384140.3116.183105.0792.98494.549126.843101.55768.23192.31466.35481.05335.53648.00342.10548.13225.71762.27336.2349.56818.68362.45329.60631.60920.90447.11933.86
Cost of Revenue 77.65141.488.872.65166.36736.62960.78975.41465.13344.57154.98437.33148.39620.21824.33922.86325.30514.96532.24320.34528.03610.99633.15414.56117.212.2527.85519.036
Gross Profit 46.66342.651.543.53238.70356.35633.7651.42936.42423.6637.3329.02332.65715.31923.66419.24222.82610.75230.02915.88521.5327.68629.29915.04514.4098.65419.26414.824
Gross Profit Ratio 0.3750.5070.3670.3750.3680.6060.3570.4050.3590.3470.4040.4370.4030.4310.4930.4570.4740.4180.4820.4380.4340.4110.4690.5080.4560.4140.4090.438
Reseach & Development Expenses 5.3692.2192.24.5814.1423.8943.4583.8522.2961.8361.3841.4322.0351.4431.1151.0240.8041.2640.9241.2041.5991.1470.0461.0481.0990.7841.1280.938
General & Administrative Expenses 18.52729.56933.65621.8091.47322.727.05718.96614.28916.73517.548.834.8669.60510.6196.58510.3248.1999.7555.69913.2488.1610.1774.9926.102-0.3120.0136.833
Selling & Marketing Expenses 4.0561.1311.1444.9451.1591.2881.3575.9864.7441.2991.2743.6690.8470.6080.61.6160.150.4890.7421.1910.4470.5620.4040.2960.660.5210.4720.587
SG&A 26.0630.734.826.7532.63123.98828.41424.95219.03318.03418.81512.4995.71310.21311.228.20110.4748.68910.4976.8913.6958.72210.5825.2886.7620.2080.0137.419
Other Expenses 5.162-0.142-0.768-1.473-0.159-0.02200-0.1630000000000000000000
Operating Expenses 36.5930.736.739.39332.20926.86731.58135.12326.69521.30820.7718.56318.17511.45112.19911.01411.3829.97411.7059.5114.99.5960.3780.2240.1620.2080.01312.2
Operating Income 9.48311.916.85.2955.10529.8672.21916.9939.9812.14717.70110.0413.7064.77411.5318.37112.7550.64519.5656.187.338-2.416-0.378-0.224-0.162-0.208-0.0135.591
Operating Income Ratio 0.0760.1420.120.0460.0490.3210.0230.1340.0980.0310.1920.1510.1690.1340.240.1990.2650.0250.3140.1710.148-0.129-0.006-0.008-0.005-0.01-00.165
Total Other Income Expenses Net -15.592-4.379-7.27-7.544-9.472-7.578-9.96-8.068-7.621-4.784-8.222-5.18-4.212-5.008-5.897-12.735-8.249-4.585-3.472-16.397-5.044-21.8680.610.5290.4570.1190-5.44
Income Before Tax -6.1097.99.6-2.249-4.36622.289-7.7418.9252.36-2.6379.484.8619.494-0.2345.635-4.3644.506-3.9416.093-10.2172.294-24.2840.2310.3040.296-0.089-0.013-0.913
Income Before Tax Ratio -0.0490.0940.068-0.019-0.0420.24-0.0820.070.023-0.0390.1030.0730.117-0.0070.117-0.1040.094-0.1530.258-0.2820.046-1.30.0040.010.009-0.004-0-0.027
Income Tax Expense -4.028-18.30.429-1.577-5.190.6855.0136.8964.344.1412.5958.1190.3913.8362.0061.368-0.3663.444-2.2393.541-1.6057.0211.973.551.5225.5660.29
Net Income -1.5319.50.108-4.592-1.70828.2-8.1570.498-5.014-6.4873.4270.8740.634-1.180.648-6.9722.215-3.12111.315-7.05-1.123-21.4750.2310.3040.296-0.089-0.013-0.826
Net Income Ratio -0.0120.1130.001-0.04-0.0160.303-0.0860.004-0.049-0.0950.0370.0130.008-0.0330.014-0.1660.046-0.1210.182-0.195-0.023-1.1490.0040.010.009-0.004-0-0.024
EPS -0.0250.150.002-0.073-0.0270.45-0.130.008-0.11-0.160.0830.0210.022-0.0310.017-0.190.057-0.0860.31-0.2-0.04-0.720.0060.0930.091-0.03-0.0010
EPS Diluted -0.0250.140.002-0.073-0.0270.45-0.130.008-0.11-0.160.0810.0210.022-0.0310.017-0.190.057-0.0860.31-0.2-0.04-0.720.0060.0930.091-0.03-0.0010
EBITDA 9.07816.21616.259.6115.8734.4753.43219.39811.2694.03519.38810.28517.8555.64112.2411.8349.915-0.04726.714-3.37811.19-2.0680.2310.3040.296-0.089-0.0136.712
EBITDA Ratio 0.0730.1460.1050.081-0.0290.3710.0810.1630.1220.0660.210.170.1070.1590.2560.2170.1220.0350.4210.2020.684-0.111-0.016-0.025-0.02-0.016-00.198